CD30-positive DLBCL usually show a centroblastic appearance, but in some cases can display anaplastic morphology; the positivity of B-cell markers (CD20, CD79) in the neoplastic cells and the absence of ALK are crucial to establish the diagnosis [133,134]. This evidence concerns the gene TNFRSF8 and diffuse large B-cell lymphoma.